rs100642 has been researched along with Disease-Models--Animal* in 1 studies
1 other study(ies) available for rs100642 and Disease-Models--Animal
Article | Year |
---|---|
Oxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642).
Breast cancer (BCa) was induced in vivo in female rats with 7,12-dimethylbenz(a)anthracene (DMBA). Two main questions were addressed. Firstly, would the carcinogenesis be accompanied by oxidative stress as signalled by superoxide dismutase, glutathione peroxidase, malondialdehyde and total nitrate? Secondly, would treating the rats additionally with a blocker of voltage-gated sodium channel (VGSC) activity, shown previously to promote BCa progression, affect the oxidative responses? The DMBA-induced increases in the antioxidant systems were completely blocked by the VGSC inhibitor RS100642, which also significantly prolonged the lifespan. We conclude that VGSC inhibition in vivo can significantly protect against oxidative stress and improve survival from tumour burden. Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Disease Models, Animal; Female; Glutathione Peroxidase; Malondialdehyde; Mammary Neoplasms, Experimental; Mexiletine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Channel Blockers; Superoxide Dismutase | 2012 |